Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Genentech Reorganization Signals Shift To New Model Under Roche

This article was originally published in The Pink Sheet Daily

Executive Summary

Roche’s Soriot will take over as CEO of Genentech, while key members of Genentech’s management will take on advisory roles or depart.

You may also be interested in...



Clinical Development Setbacks, Pricing Pressures Hit Roche

Recent setbacks for two of its most important pipeline projects, as well as a tougher pricing environment in key Western countries, will take a toll on Roche in 2010 and beyond, company executives told analysts during a half-year earnings call on July 22

Clinical Development Setbacks, Pricing Pressures Hit Roche

Recent setbacks for two of its most important pipeline projects, as well as a tougher pricing environment in key Western countries, will take a toll on Roche in 2010 and beyond, company executives told analysts during a half-year earnings call on July 22

Clinical Development Setbacks, Pricing Pressures Hit Top, Bottom Lines at Roche

"The financial crisis has arrived for the pharmaceutical industry," says CEO Severin Schwan.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS069277

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel